{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:12:55Z","timestamp":1788307975267,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer US","isbn-type":[{"value":"9781071653913","type":"print"},{"value":"9781071653920","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5392-0_14","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:19:40Z","timestamp":1788304780000},"page":"265-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Yenos\/MinION Multi-Cancer Early Detection Liquid Biopsy Test: An Innovative Approach to MicroRNA Quantification"],"prefix":"10.1007","author":[{"given":"Anastassia","family":"Kanavarioti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"1","key":"14_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03960-8","volume":"21","author":"S Connal","year":"2023","unstructured":"Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, Perlow H, Baker MJ (2023) Liquid biopsies: the future of cancer early detection. J Transl Med 21(1):118. https:\/\/doi.org\/10.1186\/s12967-023-03960-8","journal-title":"J Transl Med"},{"issue":"5","key":"14_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/cancers15051579","volume":"15","author":"A Armakolas","year":"2023","unstructured":"Armakolas A, Kotsari M, Koskinas J (2023) Liquid biopsies, novel approaches and future directions. Cancers 15(5):1579. https:\/\/doi.org\/10.3390\/cancers15051579","journal-title":"Cancers"},{"issue":"7006","key":"14_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350\u2013355. https:\/\/doi.org\/10.1038\/nature02871","journal-title":"Nature"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105.","volume":"105","author":"P Mitchell","year":"2008","unstructured":"Mitchell P et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"14_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/genes14020314","volume":"14","author":"G Iacomino","year":"2023","unstructured":"Iacomino G (2023) miRNAs: the road from bench to bedside. Genes (Basel) 14(2):314. https:\/\/doi.org\/10.3390\/genes14020314","journal-title":"Genes (Basel)"},{"issue":"12","key":"14_CR6","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1016\/j.celrep.2019.11.078","volume":"29","author":"PM Godoy","year":"2019","unstructured":"Godoy PM, Barczak AJ, DeHoff P et al. (2019) Comparison of reproducibility, accuracy, sensitivity, and specificity of miRNA quantification platforms. Cell Rep 29(12):4212\u20134222. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.078 e5","journal-title":"Cell Rep"},{"issue":"10","key":"14_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA et al. (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10(10):1003\u20131005. https:\/\/doi.org\/10.1038\/nmeth.2633 (see Fig. 2c for miR-141 data spread and overlap)","journal-title":"Nat Methods"},{"issue":"1","key":"14_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76667-1","volume":"10","author":"ASW Kang","year":"2020","unstructured":"Kang ASW, Bernasconi JG, Jack W, Kanavarioti A (2020) Ready-to-use nanopore platform for the detection of any DNA\/RNA oligo at attomole range using an Osmium tagged complementary probe. Sci Rep 10(1):19790. https:\/\/doi.org\/10.1038\/s41598-020-76667-1","journal-title":"Sci Rep"},{"key":"14_CR9","unstructured":"Kanavarioti A, Kang ASW See RNA(OsBp) event detection python package in a public repository. Third revision by Garret D. Grant, see https:\/\/github.com\/garretdgrant\/osbp_detect?tab=readme-ov-file#quick-start"},{"key":"14_CR10","doi-asserted-by":"publisher","unstructured":"Kanavarioti A Femtomolar-level PCR-free quantification of microRNA cancer biomarkers in serum, posted in BioRxiv, https:\/\/doi.org\/10.1101\/2022.12.30.522268","DOI":"10.1101\/2022.12.30.522268"},{"issue":"4","key":"14_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ncrna10040042","volume":"10","author":"A Kanavarioti","year":"2024","unstructured":"Kanavarioti A, Rehman MH, Qureshi S, Rafiq A, Sultan M (2024) High sensitivity and specificity platform to validate microRNA biomarkers in cancer and human diseases. Non-Coding RNA 10(4):42. https:\/\/doi.org\/10.3390\/ncrna10040042","journal-title":"Non-Coding RNA"},{"issue":"8","key":"14_CR12","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.3390\/ijms26083822","volume":"26","author":"A Rafiq","year":"2025","unstructured":"Rafiq A, Kanavarioti A (2025) The potential and limitations of the MinION\/Yenos platform for miRNA-enabled early cancer detection. Int J Mol Sci 26(8):3822. https:\/\/doi.org\/10.3390\/ijms26083822","journal-title":"Int J Mol Sci"},{"key":"14_CR13","unstructured":"Oxford Nanopore Technologies, Inc. https:\/\/nanoporetech.com"}],"container-title":["Methods in Molecular Biology","MicroRNA Target Identification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5392-0_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:19:41Z","timestamp":1788304781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5392-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653913","9781071653920"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5392-0_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Anastassia Kanavarioti is the founder, inventor and director of Yenos Analytical LLC, a company that delivers custom analytical solutions for native, synthetic, or transcribed nucleic acids and engages in the development and manufacturing of labeled\/tagged nucleic acids for use in conjunction with nanopore detection and nucleic acid quantification, including miRNAs, with awarded patents for\n                      Nanopore platform for DNA\/RNA oligo detection using an osmium tagged complementary probe\n                      , Patent No: US 11,111,527 B1, issued 9-7-2021 and US 11,427,859, issued 9-30-2022 and\n                      Osmium Tagged Probes for Nucleic Acid Detection\n                      , US 11,884,968, issued 01-30-2024. International patents are pending in Europe, Canada, Australia, Japan\u00a0(awarded No 7857933), China, India, Brazil, and South Korea. There is no competing interest or relationship (commercial, financial, or nonfinancial) between the two companies, namely, Oxford Nanopore Technologies and Yenos Analytical LLC, and their employees.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}